From: Type 2 diabetes and cardiometabolic risk may be associated with increase in DNA methylation of FKBP5
Characteristic | Percentage or mean (standard deviation) |
---|---|
Sex (%) | |
Female | 48.8% (n = 21) |
Race (%) | |
Non-Hispanic White | 37.2% (n = 16) |
Non-Hispanic Black | 60.5% (n = 26) |
Asian | 2.3% (n = 1) |
Age (years) | 61.9 ± 9.0 |
WC (cm) | 109.7 ± 21.6 |
WC ≥ 94 cm (men) or 80 cm (women) (%) | 81.5% (n = 35) |
BMI (kg/m2) | 34.1 ± 8.3 |
Antihypertensive medication use (%) | 100% (n = 43) |
HbA1c (%) | 8.3 ± 1.6 |
LDL cholesterol (mg/dL) | 89 ± 40 |
Cardiovascular procedure (%)* | |
Catheterization | 11.6% (n = 5) |
Percutaneous coronary intervention (PCI) | 4.7% (n = 2) |
Coronary artery bypass surgery (CABG) | 7.0% (n = 3) |
PCI and CABG | 4.7% (n = 2) |